We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.
News
-
2019 Staff Flu Vaccinations campaign at The Royal Marsden
1 October 2019
We at The Royal Marsden launch our 2019 Flu campaign to vaccinate staff working closely with patients.
Read more -
Breast cancer drug outperforms targeted hormone therapy in some men with advanced prostate cancer
30 September 2019
A drug used for breast and ovarian cancer is more effective at slowing progression and improving survival in some men with advanced prostate cancer than modern targeted hormone treatments, phase III clinical trial findings reveal.
Read more -
Research on a mesothelioma trial suggests important clues to providing improved treatments for thousands of patients each year
30 September 2019
Professor Sanjay Popat, Consultant Medical Oncologist presented his research which compared the effects of immunotherapy with the checkpoint inhibitor, pembrolizumab, to standard chemotherapy after patients with mesothelioma relapsed on or after their first treatment.
Read more -
Combination immunotherapy drugs herald new hope for melanoma patients with long term survival rates hitting an all-time high
28 September 2019
A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.
Read more -
Largest ever trial in postoperative prostate cancer patients confirms that men can be spared radiotherapy after surgery
27 September 2019
Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results from a study led by The Royal Marsden NHS Foundation Trust.
Read more -
World Pharmacists Day 2019
25 September 2019
The Pharmacy Department at the Royal Marsden employs a team of around 180 Pharmacy Assistants, Technicians and Pharmacists across the three main hospital sites.
Read more -
MR Linac- One year on
24 September 2019
The Royal Marsden treated its first cervical cancer patient using the pioneering MR Linac just weeks before we marked our first year of treating patients.
Read more -
Targeted drug for paediatric patients receives EU approval
23 September 2019
A new class of cancer drug that was trialled in the Oak Paediatric and Adolescent Drug Development Unit at The Royal Marsden has been approved for use in Europe.
Read more -
Immunotherapy trial targets bowel cancer
20 September 2019
The Royal Marsden is leading one of the world’s first trials of immunotherapy in bowel cancer that has been removed by surgery.
Read more -
Study signals new era of precision medicine for children with cancer
19 September 2019
A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.
Read more